Article
The Potential Clinical and Economic Value of a Human Papillomavirus Primary Screening Test That Additionally Identifies Genotypes 31, 45, 51, and 52 Individually.
Sexually transmitted diseases - 1 May 2021
Asti Lindsey, Hopley Colin, Avelis Cameron, Bartsch Sarah M, Mueller Leslie E, Domino Molly, Cox Sarah N, Andrews Jeffrey C, Randall Samuel L, Stokes-Cawley Owen J, Asjes Caitlin, Lee Bruce Y
Abstract excerpt
BACKGROUND: Although current human papillomavirus (HPV) genotype screening tests identify genotypes 16 and 18 and do not specifically identify other high-risk types, a new extended genotyping test identifies additional individual (31, 45, 51, and 52) and groups (33/58, 35/39/68, and 56/59/66) of high-risk genotypes. METHODS: We developed a Markov model of the HPV disease course and evaluated the clinical and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
